Friday, 29 October 2021

Australia's most trusted
source of pharma news

Friday, 29 October 2021

Who has pharma's best rep?

Posted 23 September 2021 AM

Rare disease patient groups have voted Roche as "best" pharma for overall corporate reputation and "best" in its response to tackling COVID-19, according to a newly released PatientView survey.

Takeda came in second place followed by Pfizer in third, after an assessment of 29 companies with which patient groups were familiar, according to the Corporate Reputation of Pharma 2020, Perspective of Rare Disease Patient Groups Report.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read. If you don't have a password, just enter your email address and then click Login.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.